UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000017085
Receipt number R000019820
Scientific Title Robot (Da Vinci) -assisted colorectal surgery
Date of disclosure of the study information 2015/04/09
Last modified on 2021/04/13 09:22:14

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Robot (Da Vinci) -assisted colorectal surgery

Acronym

Robot-assisted colorectal surgery

Scientific Title

Robot (Da Vinci) -assisted colorectal surgery

Scientific Title:Acronym

Robot-assisted colorectal surgery

Region

Japan


Condition

Condition

Colorectal cancer

Classification by specialty

Gastrointestinal surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

Assessing the safety and efficacy of robot-assisted colorectal cancer surgery

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

operation time, blood loss

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Device,equipment

Interventions/Control_1

Robot-assisted colorectal surgery using da Vinci Surgical System will be performed.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

80 years-old >=

Gender

Male and Female

Key inclusion criteria

1. Colorectal cancer proven histologically.
2. No distant metastasis.
3. No invasion to the adjacent organ.
4. Age under 80
5. Performance Status 0 / 1
6. Written informed consent.

Key exclusion criteria

1. abalienation or disorder of other cognitive functioning
2. Platelet count under 50,000/micro-litter, prothrombin time under 80%
3. Severe disorder of liver function
4. Severe disorder of renal function
5. Severe disorder of heart function
6. Patient with high possibility of intraabdominal adhesion
7. Patient without consent of blood transfusion
8. Other conditions judged ineligible by physician.

Target sample size

5


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Toshiaki Watanabe

Organization

The university of Tokyo

Division name

Department of surgical oncology

Zip code


Address

Hongo 7-3-1, Bunkyo-ku, Tokyo, Japan

TEL

03-3815-5411

Email

toshwatanabe@yahoo.co.jp


Public contact

Name of contact person

1st name
Middle name
Last name Eiji Sunami

Organization

The university of Tokyo

Division name

Department of surgical oncology

Zip code


Address

Hongo 7-3-1, Bunkyo-ku, Tokyo, Japan

TEL

03-3815-5411

Homepage URL


Email

eijisunami@gmail.com


Sponsor or person

Institute

Department of surgical oncology,
The university of Tokyo

Institute

Department

Personal name



Funding Source

Organization

University of Tokyo hospital

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2015 Year 04 Month 09 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2012 Year 04 Month 01 Day

Date of IRB

2012 Year 04 Month 01 Day

Anticipated trial start date

2012 Year 04 Month 01 Day

Last follow-up date

2020 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2015 Year 04 Month 09 Day

Last modified on

2021 Year 04 Month 13 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000019820


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name